| HMDB0003125 | Hydrogen peroxide | 7722-84-1 |  | H2O2 | 34.0147
34.005479308 | Not Available |
| HMDB0002111 | Water | 7732-18-5 |  | H2O | 18.0153
18.010564686 | Not Available |
| HMDB0059597 | Hydrogen Ion | |  | H | 1.0079
1.007825032 | Not Available |
| HMDB0000692 | Fe2+ | 15438-31-0 |  | Fe | 55.845
55.934942133 | Not Available |
| HMDB0002306 | Hydrochloric acid | 7647-01-0 |  | ClH | 36.461
35.976677739 | Not Available |
| HMDB0014656 | Cisplatin | 15663-27-1 |  | Cl2H4N2Pt | 298.035
296.939928001 | - Erdogan S, Tosyali E, Duzguner V, Kucukgul A, Aslantas O, Celik S: Cisplatin reduces Brucella melitensis-infected cell number by inducing apoptosis, oxidant and pro-inflammatory cytokine production. Res Vet Sci. 2010 Apr;88(2):218-26. doi: 10.1016/j.rvsc.2009.09.002. Epub 2009 Oct 8. [PubMed:19818462 ]
- Ozen S, Akyol O, Iraz M, Sogut S, Ozugurlu F, Ozyurt H, Odaci E, Yildirim Z: Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol. 2004 Jan-Feb;24(1):27-35. [PubMed:14745844 ]
|
| HMDB0012974 | Hypothiocyanite | 63296-34-4 |  | CHNOS | 75.09
74.977884349 | Not Available |
| HMDB0001875 | Methanol | 67-56-1 |  | CH4O | 32.0419
32.02621475 | Not Available |
| HMDB0001426 | Formaldehyde | 50-00-0 |  | CH2O | 30.026
30.010564686 | Not Available |
| HMDB0000464 | Calcium | 7440-70-2 |  | Ca | 40.078
39.962591155 | Not Available |
| HMDB0000033 | Carnosine | 305-84-0 |  | C9H14N4O3 | 226.2325
226.106590334 | - Boldyrev A, Abe H, Stvolinsky S, Tyulina O: Effects of carnosine and related compounds on generation of free oxygen species: a comparative study. Comp Biochem Physiol B Biochem Mol Biol. 1995 Nov;112(3):481-5. [PubMed:8529024 ]
|
| HMDB0000159 | Phenylalanine | 63-91-2 |  | C9H11NO2 | 165.1891
165.078978601 | Not Available |
| HMDB0003654 | 4-Coumaryl alcohol | 20649-40-5 |  | C9H10O2 | 150.1745
150.068079564 | Not Available |
| HMDB0010715 | 2-Phenylacetamide | 103-81-1 |  | C8H9NO | 135.1632
135.068413915 | Not Available |
| HMDB0014389 | Mesalazine | 89-57-6 |  | C7H7NO3 | 153.1354
153.042593095 | - Nandi J, Saud B, Zinkievich JM, Palma DT, Levine RA: 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats. Dig Dis Sci. 2008 Jan;53(1):123-32. Epub 2007 May 15. [PubMed:17503181 ]
|
| HMDB0014378 | Aminosalicylic Acid | 65-49-6 |  | C7H7NO3 | 153.1354
153.042593095 | - von Ritter C, Grisham MB, Granger DN: Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum. Gastroenterology. 1989 Mar;96(3):811-6. [PubMed:2563347 ]
- Gorgulu S, Yagci G, Kaymakcioglu N, Ozkara M, Kurt B, Ozcan A, Kaya O, Sadir S, Tufan T: Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci. 2006 Mar;51(3):480-7. [PubMed:16614956 ]
|
| HMDB0000062 | L-Carnitine | 541-15-1 |  | C7H15NO3 | 161.1989
161.105193351 | - Derin N, Agac A, Bayram Z, Asar M, Izgut-Uysal VN: Effects of L-carnitine on neutrophil-mediated ischemia-reperfusion injury in rat stomach. Cell Biochem Funct. 2006 Sep-Oct;24(5):437-42. [PubMed:16130180 ]
|
| HMDB0014690 | Propylthiouracil | 51-52-5 |  | C7H10N2OS | 170.232
170.051383642 | - Lee E, Miki Y, Katsura H, Kariya K: Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem Pharmacol. 1990 May 1;39(9):1467-71. [PubMed:2159305 ]
- Kariya K, Lee E, Hirouchi M: Relationship between leukopenia and bone marrow myeloperoxidase in the rat treated with propylthiouracil. Jpn J Pharmacol. 1984 Oct;36(2):217-22. [PubMed:6096612 ]
- Zhang AH, Chen M, Gao Y, Zhao MH, Wang HY: Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis. Clin Immunol. 2007 Feb;122(2):187-93. Epub 2006 Oct 27. [PubMed:17070108 ]
- Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K: Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol. 1988 Jun 1;37(11):2151-3. [PubMed:2837228 ]
|
| HMDB0014262 | Octreotide | 83150-76-9 |  | C49H66N10O10S2 | 1019.239
1018.440479762 | - Alatas E, Alatas O, Colak O: Octreotide inhibits myeloperoxidase activity in rat uterus. Acta Obstet Gynecol Scand. 2000 Jul;79(7):524-7. [PubMed:10929949 ]
- Alatas E, Gunal O, Alatas O, Colak O: Octreotide prevents postoperative adhesion formation by suppressing peritoneal myeloperoxidase activity. Hepatogastroenterology. 2000 Jul-Aug;47(34):1034-6. [PubMed:11020872 ]
|
| HMDB0031219 | Ethyl carbamate | 51-79-6 |  | C3H7NO2 | 89.0932
89.047678473 | - Kotanidou A, Choi AM, Winchurch RA, Otterbein L, Fessler HE: Urethan anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release. J Appl Physiol (1985). 1996 Nov;81(5):2305-11. [PubMed:8941558 ]
|
| HMDB0003178 | Heme | 14875-96-8 |  | C34H32FeN4O4 | 616.487
616.177297665 | Not Available |
| HMDB0015567 | Calcipotriol | 112965-21-6 |  | C27H40O3 | 412.6047
412.297745146 | - Sato H, Ogino Y, Takagi H, Hata J, Asano S, Ohta T, Komoriya K: Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice. J Dermatol. 2003 Jul;30(7):510-24. [PubMed:12928540 ]
|
| HMDB0014604 | Nabumetone | 42924-53-8 |  | C15H16O2 | 228.2863
228.115029756 | - Saleh TS, Calixto JB, Medeiros YS: Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999;20(8):949-56. [PubMed:10503773 ]
|
| HMDB0014971 | Cefaclor | 53994-73-3 |  | C15H14ClN3O4S | 367.807
367.039354348 | - Zuccotti G, Dauria E, Torcoletti M, Lodi F, Bernardo L, Riva E: Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children. J Int Med Res. 2001 Jul-Aug;29(4):349-54. [PubMed:11675909 ]
|
| HMDB0013921 | 7-Hydroxyticlopidine | |  | C14H14ClNOS | 279.785
279.048462472 | - Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
